GLUT1 expression has been shown to be correlated with tumor FDG uptake in salivary gland pleomorphic adenomas [44], esophageal squamous cell carcinoma [45], and high-risk prostate cancer [46]. This evidence concerns the gene SLC2A1 and Familial prostate cancer.